Skip to content

Clinical Observation on the Therapeutic Efficacy of Along-Meridian Fixed-Point Gua Sha Combined with Acupuncture for Cervicogenic Headache of the Qi Stagnation and Blood Stasis Pattern

Clinical Observation on the Therapeutic Efficacy of Along-Meridian Fixed-Point Gua Sha Combined with Acupuncture for Cervicogenic Headache of the Qi Stagnation and Blood Stasis Pattern

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001679
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache

Interventions

Treatment Group:Receive "meridian-guided, fixed-point" gua sha combined with conventional acupuncture treatment as recommended in the textbook.
Control Group:Only standard acupuncture treatments recommended in textbooks are accepted.

Sponsors

Wangjing Hospital of the China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the aforementioned CEH diagnostic criteria for diseases in both Western and Traditional Chinese Medicine, as well as the diagnostic criteria for Traditional Chinese Medicine syndrome patterns; (2) Aged 18–60 years, regardless of gender; (3) Have not received any other treatments that may affect the results within 15 days prior to treatment; (4) Are willing to accept and cooperate with acupuncture and gua sha treatments; (5) Voluntarily participate in this study, have carefully read the precautions, and are able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals who have systematically used glucocorticoids, anticonvulsants, or tricyclic antidepressants within the past month for headaches or other pain conditions; (2) Individuals with congenital disorders or structural abnormalities of the head and neck, or a recent history of trauma to these areas; (3) Individuals with coagulation disorders or those currently taking anticoagulants or antiplatelet medications, as well as those with local skin ; (4) Individuals with severe concomitant primary diseases of the heart, lungs, liver, kidneys, or hematological system, or psychiatric disorders that may affect treatment or assessment; (5) Women who are pregnant, breastfeeding, or planning to become pregnant during the study period; (6) Individuals whom the investigator determines to have other conditions rendering them unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale for Pain;

Secondary

MeasureTime frame
Headache Impact Assessment-6;Neck Disability Index;Traditional Chinese Medicine Syndrome Scoring;

Countries

China

Contacts

Public ContactYuan Ying

Wangjing Hospital of the China Academy of Chinese Medical Sciences

yingyin0007@126.com13683272723

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026